Commonwealth Equity Services’s BIO-key International BKYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-122
Closed -$48K 3713
2021
Q4
$48K Buy
+122
New +$61.6K ﹤0.01% 3537
2021
Q1
Sell
-231
Closed -$146K 3402
2020
Q4
$146K Buy
231
+196
+560% +$124K ﹤0.01% 2996
2020
Q3
$22K Buy
+35
New +$33.1K ﹤0.01% 3006
2019
Q4
Sell
-50
Closed -$44K 2893
2019
Q3
$44K Sell
50
-11
-18% -$15.1K ﹤0.01% 2749
2019
Q2
$107K Hold
61
﹤0.01% 2624
2019
Q1
$129K Hold
61
﹤0.01% 2563
2018
Q4
$65K Hold
61
﹤0.01% 2546
2018
Q3
$122K Hold
61
﹤0.01% 2612
2018
Q2
$233K Hold
61
﹤0.01% 2334
2018
Q1
$188K Hold
61
﹤0.01% 2425
2017
Q4
$155K Buy
61
+6
+11% +$16.8K ﹤0.01% 2439
2017
Q3
$226K Buy
+55
New +$252K ﹤0.01% 2184

Other funds holding BKYI

Commonwealth Equity Services's BKYI Position: Q1 2022 in Review

Commonwealth Equity Services sold out of BIO-key International (BKYI) in Q1 2022, closing a stake of 122 shares — an estimated $48K sold.

Commonwealth Equity Services first reported a position in BKYI in Q3 2017 and held it in 12 quarters. The position peaked at $233K in Q2 2018. 12 funds tracked by Wall St. Rank hold BKYI as of Q1 2022.

  • Commonwealth Equity Services reported no remaining BIO-key International position as of Q1 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 122 BIO-key International shares in Q1 2022, an estimated $48K.
  • Commonwealth Equity Services first reported a position in BIO-key International in Q3 2017 and held it in 12 quarters.
  • Commonwealth Equity Services's BIO-key International position peaked at $233K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held BIO-key International as of Q1 2022.

Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.